This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Looking for reliable websites to aid your investment learning? Check out our curated list of resources that support new investors on their journey.
28,161 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Investors are eyeing a wave of next generation submarines as major powers expand fleets, raising costs and creating n...
Pfizer's stock has lagged since 2021, but the story isn’t over. This guide breaks down why pfizer stock: still priced...
A traditional publishing house rethinks growth with a bold AI push. A key investor just added $7 million to their sta...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
When a tech hardware stock plunges, questions surge. This guide explains the drivers behind super micro stock crashin...
A potential power crunch may unlock a rare upside for energy investors. This guide explains why baseload assets like ...
A bold IPO from Quantinuum has lit a new phase for quantum stocks. As quantinuum's putting pressure ionq, investors n...
A surprising collaboration between Stellantis and Carvana could reshuffle auto retail. This article breaks down why t...
Lightstone opens access to 25,000+ multifamily units for accredited investors as rents rise in tight markets. The mov...
Investors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...
When lululemon shares dropped after the company cut its annual forecast, it sent a clear message about the market's g...